Korean
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

etoposide/유방암

링크가 클립 보드에 저장됩니다.
페이지 1 ...에서 722 결과

Chronic oral etoposide in advanced breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
Chronic oral etoposide has shown activity in some metastatic refractory tumors. To test its activity in previously treated metastatic breast cancer patients, we started a study in 18 consecutive patients given etoposide orally at 50 mg/m2 daily for 21 days. A partial response was observed in 4 of 18

Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
We report a high risk of therapy-related acute myeloid leukemia and myelodysplastic syndrome (t-AML/MDS) in patients receiving oral administration of etoposide for recurrent breast cancer. We examined 119 patients with recurrent disease. Patients were initially treated with anthracyclines,

[Efficacy of etoposide in bone metastasis of breast cancer].

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
We have used ADM, MMC, CDDP and other drugs for a case of bone metastasis of breast cancer, but the bone destruction was advanced and she could not walk. We have also used etoposide, a new chemotherapeutic drug, for the same case. Two months later bone sclerosis was seen by X-ray film and pain

High-dose etoposide in treatment of metastatic breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
High-dose etoposide (1,500-2,500 mg/m2) was used for the treatment of 23 previously treated patients with advanced breast cancer. Six of 23 (26%) showed objective regression with a median duration of response of 5 months. Responses were seen at all sites apart from bone. Response was related to dose

Doxorubicin and etoposide in the treatment of advanced measurable breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
Nineteen evaluable patients with advanced breast cancer were treated with a combination of doxorubicin and etoposide. Patients had measurable disease, received only mild pretreatment and most had good general conditions at start of therapy. Strict criteria for dose adjustments according to nadir

DNA repair in Etoposide-induced DNA damage in lymphocytes of breast cancer patients and healthy women.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
The present study evaluated the basal DNA damage and the cellular response to this damage induced by in vitro administration of Etoposide in lymphocytes donated by twenty untreated breast cancer (BC) patients and twenty age-matched healthy women. Micronucleus (MN) and alkaline Comet assays were

Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
The pharmacokinetics and pharmacodynamics of prolonged oral etoposide chemotherapy were investigated in 15 women with metastatic breast cancer who received oral etoposide 100 mg as a single daily dose for up to 15 days. There was considerable interpatient variability in the day 1 pharmacokinetic

Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
Carboplatin is used in many kind of tumors with similar results to cisplatin but without the same toxicity. We decided to use it, in combination with etoposide, for metastatic breast cancer. Eighteen women with advanced breast disease entered this phase II study. Each of them received, every 28

Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE To determine the efficacy and toxicity of the carboplatin and oral etoposide combination in patients with advanced breast cancer previously treated with anthracyclines. METHODS Twenty-seven patients were treated with a maximum of 6 cycles of carboplatin (300 mg/m2) and etoposide (200
Tumor microenvironment play role in angiogenesis and carcinogenesis. Etoposide, a known topoisomerase II inhibitor induces DNA damage resulting in cell cycle arrest. We developed a novel Etoposide analogue, Quinazolino-4β-amidopodophyllotoxin (C-10) that show better efficacy in regulating cell

Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
The object of the study was to evaluate the effectiveness of ifosfamide/etoposide and mesna therapy in advanced breast cancer. A total of 44 patients with breast cancer were included in the trial. Eligibility criteria included measurable, refractory disease; prior anthracycline therapy (or its
Macrophage inflammatory protein-1alpha (MIP-1alpha) is a chemokine that can inhibit the cell cycle progression of both primitive haemopoietic and epidermal progenitor cells. This property could potentially be exploited to attenuate both the myelosuppressive effects of chemotherapy as well as

Combination chemotherapy with oral etoposide plus intravenous cyclophosphamide in liver metastases of breast cancer.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
Sixteen patients with hepatic metastases of histologically documented breast cancer were treated with etoposide (VP 16-213) and cyclophosphamide. Previously, 6 had shown relapse in the liver after adjuvant chemotherapy, 2 had failed to respond to another chemotherapy combination, and 8 had never
We have recently treated 66 women with breast cancer with escalating doses of ifosfamide, carboplatin, and etoposide (ICE) followed by autologous stem cell rescue (ASCR). Patients received ifosfamide (6000-24,000 mg m-2), carboplatin (1200-2100 mg m-2), and etoposide (1800-3000 mg m-2) divided over

Vinorelbine/VP-16 (etoposide) in metastatic breast cancer: a phase II study.

등록 된 사용자 만 기사를 번역 할 수 있습니다.
로그인 / 가입
OBJECTIVE This phase II study was conducted to evaluate the efficacy and tolerability of vinorelbine (navelbine) and oral VP-16 (etoposide) in pretreated metastatic breast cancer (MBC) patients. METHODS Twenty-two female patients with therapy-resistant metastatic breast cancer were treated with
페이스 북
페이지에 가입하세요

과학이 뒷받침하는 가장 완벽한 약초 데이터베이스

  • 55 개 언어로 작동
  • 과학이 뒷받침하는 약초 치료제
  • 이미지로 허브 인식
  • 인터랙티브 GPS지도-위치에 허브 태그 지정 (출시 예정)
  • 검색과 관련된 과학 출판물 읽기
  • 효과로 약초 검색
  • 관심사를 정리하고 뉴스 연구, 임상 실험 및 특허를 통해 최신 정보를 확인하세요.

증상이나 질병을 입력하고 도움이 될 수있는 약초에 대해 읽고 약초를 입력하고 사용되는 질병과 증상을 확인합니다.
* 모든 정보는 발표 된 과학 연구를 기반으로합니다.

Google Play badgeApp Store badge